General Information
Version
5.8. Revision Date
Revision date
2023-06-20
Product name
4-methyl-1,4lambda5-azaphosphinan-4-one hydrochloride
Product name
4-methyl-1,4lambda5-azaphosphinan-4-one hydrochloride
Identification on the label/Trade name
EN300-367265
CAS No.
945459-80-3
REACH No
A
1.2.1 Relevant identified uses
of the substance and restrictions on use
supplier name
ENAMINE Ltd
Emergency telephone
+38 044 495 88 17, +380 44 5373253
Icons in SDS
Company Information
company name
ENAMINE Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@enamine.net
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H341, H351, H360FD
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance / mixture
Hazard pictograms
� � � � � � � � � �
Signal word
Danger
Hazard statements
H301 Toxic if swalloed H341 Suspected of causing genetic defects H351 Suspected of causing cancer H360FD May damage fertility. May damage the unborn child
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash hands thoroughly after handling. Wash skin thouroughly after handling. P270 Do not eat, drink or smoke when using this product. P281 Use personal protective equipment as required. P308+P313 IF exposed or concerned: Get medical advice/attention. P310 Immediately call a POISON CENTER or doctor/physician. P330 Rinse mouth. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards
N/A
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, oral(Category 3), H301 Germ cell mutagenicity(Category 2), H341 Carcinogenicity(Category 2), H351 Reproductive toxicity(Category 1A), H360FD For the full text of the H-Statements mentioned in this Section, see Section 2.2. 1
